Merck

Events

• Moderna stock soars 150% after melanoma vaccine success

Recent coverage

• Merck and Moderna present vaccine reducing risk of death from skin cancer by 42% — Коммерсантъ
• Moderna shares doubled after successful cancer vaccine trial — Вечерняя Москва
• After reports of successful clinical trials of cancer vaccine, Moderna shares rose more than double — ЭХО / Новости